Psychiatry Res., 183, 1-20
(2010).
3. Balaratnasingam C., et al., Invest Ophthalmol
Vis Sci., 51, 3019-28 (2010).
4. Beirowski B., et al., J Neurosci, 29, 653-68
(2009).
5. Wang Q. and Green SH
functions as a heterodimer that consists of a
25 kDa subunit and one of the 59 kDa, 68 kDa or 72
kDa subunits.3 CPSF6 is the 68 kDa subunit. It contains
an N-terminal RNP-type RNA binding domain (RBD),
which
functions as a heterodimer that consists of a 25
kDa subunit and one of the 59 kDa, 68 kDa or 72 kDa
subunits.3 CPSF6 is the 68 kDa subunit. It contains an
N-terminal RNP-type RNA binding domain (RBD),
which
inflammatory exudate) which also contain CINC-1 (Cat.
No. C-262) and CINC-3. Both mature CINC-2α and
CINC-2β contain 68 amino acid residues. The amino
acid sequences of the CINC-2 proteins are identical
inflammatory exudate) which also contain CINC-1 (Cat.
No. C-262) and CINC-3. Both mature CINC-2α and
CINC-2β contain 68 amino acid residues. The amino
acid sequences of the CINC-2 proteins are identical
Please see reverse side of the invoice or packing slip.
6. Clemetson, K.J., Thromb. Haemost., 98, 63-68
(2007).
7. Li, S., et al., J. Thromb. Haemost., 8, 341-350
(2010).
8. Ramasamy, I., Crit.
Fundamental Cancer
Research, February, 41-63 (1967).
4. Moore, G.E., and Kitamura, H., Cell Line Derived
from Patient with Myeloma. NY State Journal of
Medicine, 68, 2054-2060 (1968).
JF,LCM,MAM 04/14
cytoplasmic membrane via the
N-terminal region of ribonuclease E. Proc. Natl.
Acad. Sci. USA, 98, 63-68 (2001).
3. Rott, R., et al., RNA polyadenylation and
degradation in cyanobacteria are similar to the
Fundamental Cancer
Research, February, 41-63 (1967).
4. Moore, G.E., and Kitamura, H., Cell Line Derived
from Patient with Myeloma. NY State Journal of
Medicine, 68, 2054-2060 (1968).
AutoMod is a trademark
type IV collagen (COL4A1) mutations: a novel
genetic multisystem disease. Curr. Opin. Neurol.,
24, 63-68 (2011).
7. Maruyama, S. et al., Metastasis-associated genes
in oral squamous cell carcinoma and
type IV collagen (COL4A1) mutations: a novel
genetic multisystem disease. Curr. Opin. Neurol.,
24, 63-68 (2011).
7. Maruyama, S. et al., Metastasis-associated genes
in oral squamous cell carcinoma and
: 1991) p. 523.
2. Kashima, N., et al., Nature, 313, 402 (1985).
3. Yokata, T., et al., Proc. Natl. Acad. Sci. USA, 82,
68 (1986).
4. Gearing, A., et al., Lymphokines and Interferons, A
PCR Program
Steps Temperature Time Cycles
Initial-denaturation 95°C 3 min
Denaturation 95°C 15 sec
Annealing* 60/63/70°C 15 sec 35
Extension 72°C 30 sec/kb
Final Extension 72°C 5 min
Immunoblotting: a working concentration of
0.1-0.2 g/mL is recommended using human fibroblasts
HS-68.
Immunohistochemistry: a working concentration of
25-50 g/mL is recommended using formalin-
PCR Program
Steps Temperature Time Cycles
Initial-denaturation 95°C 3 min
Denaturation 95°C 15 sec
Annealing 60/63/70°C 15 sec 35
Extension* 72°C 30 sec/kb
Final Extension 72°C 5 min
Expression of T-cell growth-factor activity after
transfection of monkey cells. Biochemistry, 82, 68-
72 (1985).
4. Gearing, A. et al., Lymphokines and Interferons, A
Practical Approach, Clemens
and indium complexes of entrochelin on Klebsiella
pneumoniae. Antimicrob. Agents Chemother., 18,
63-68 (1980).
VNC,DWF,MAM 04/10-1
Sigma brand products are sold through Sigma-Aldrich, Inc.
Sigma-
type IV collagen (COL4A1) mutations: a novel
genetic multisystem disease. Curr. Opin. Neurol.,
24, 63-68 (2011).
7. Maruyama, S. et al., Metastasis-associated genes
in oral squamous cell carcinoma and
. Sci. USA, 98, 63-68 (2001).
3. Soreq, H., and Littauer, U.Z., Purification and
characterization of polynucleotide phosphorylase
from Escherichia coli. Probe for the analysis of 3′
sequences of RNA
Fundamental Cancer Research, February, 41-63
(1967).
4. Moore, G.E., and Kitamura, H., Cell Line Derived from Patient with Myeloma. NY State Journal of Medicine, 68,
2054-2060 (1968).
JF,LCM,MAM 07/
C-terminal of human ATP13A2
(GeneID 23400) conjugated to KLH. The corresponding
sequence has 68% identity in rat and 63% identity in
mouse ATP13A2. The antibody is affinity-purified using
the immunizing peptide
Fundamental Cancer Research, February, 41-63
(1967).
4. Moore, G.E., and Kitamura, H., Cell Line Derived from Patient with Myeloma. NY State Journal of Medicine, 68,
2054-2060 (1968).
JF,LCM,MAM 07/